Resources and Reference materials

Home / Resources

Learning Center

Latest Videos & Webinars

Upcoming Seminar

Virtual Seminar (Europe): Precision Molecular Analysis – Examples in Oncology

June 22, 2021

PGx,

Interview: How the MassARRAY Enabled Biron to Reliably Test CYP2D6 Copy Number Variation

Watch Video

SARS-CoV-2 Testing,

Webinar: Responding to Emerging SARS-CoV-2 Variants - Impact on Existing Diagnostic Testing, Clinical Utility of Differentiation Assays

Watch Video

PGx,

Webinar: Evaluating Drug-Drug Interactions – Implications of Phenoconversions

Watch Video

View All Videos & Webinars

Featured Publications

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice

PGx , , 2020

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Liquid Biopsy , , 2020

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

Liquid Biopsy , , 2020

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer

Methylation , , 2020

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry

Infectious Disease , , 2020

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

PGx , , 2019

View All Publications

Latest Videos & Webinars

Upcoming Seminar

Virtual Seminar (Europe): Precision Molecular Analysis – Examples in Oncology

PGx,

Interview: How the MassARRAY Enabled Biron to Reliably Test CYP2D6 Copy Number Variation

SARS-CoV-2 Testing,

Webinar: Responding to Emerging SARS-CoV-2 Variants - Impact on Existing Diagnostic Testing, Clinical Utility of Differentiation Assays

PGx,

Webinar: Evaluating Drug-Drug Interactions – Implications of Phenoconversions

Featured Publications

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Featured Product Literature

MassARRAY^® System Brochure

SARS-CoV-2 (EUA) Panel Product Sheet

Oncology Solutions Brochure

Need Support?

Learning Center

Latest Videos & Webinars

Upcoming Seminar

Virtual Seminar (Europe): Precision Molecular Analysis – Examples in Oncology

PGx,

Interview: How the MassARRAY Enabled Biron to Reliably Test CYP2D6 Copy Number Variation

SARS-CoV-2 Testing,

Webinar: Responding to Emerging SARS-CoV-2 Variants - Impact on Existing Diagnostic Testing, Clinical Utility of Differentiation Assays

PGx,

Webinar: Evaluating Drug-Drug Interactions – Implications of Phenoconversions

Featured Publications

Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Mass Spectrometry as a Highly Sensitive Method for Specific Circulating Tumor DNA Analysis in NSCLC: A Comparison Study

Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry

An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes

Featured Product Literature

MassARRAY® System Brochure

SARS-CoV-2 (EUA) Panel Product Sheet

Oncology Solutions Brochure

Need Support?

MassARRAY^® System Brochure